Combination of cardioprotective glucose-lowering drugs and statins on cardiovascular mortality in diabetes: a nationwide cohort study.

In individuals with type 2 diabetes, treatment with a combination of cardioprotective glucose-lowering drug and statin was associated with a lower risk of cardiovascular mortality than using either drug alone.